Mayo Clinic proceedings
-
Mayo Clinic proceedings · Mar 2020
Multicenter Study Observational StudyPrevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation.
To estimate the prevalence of nonalcoholic fatty liver disease (NAFLD) and its impact on bleeding and thrombotic events in patients with atrial fibrillation (AF). ⋯ NAFLD is highly prevalent in AF but is not associated with higher bleeding or thrombotic risk.